These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 11313005)

  • 41. CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.
    Nikiforow S; Bottomly K; Miller G
    J Virol; 2001 Apr; 75(8):3740-52. PubMed ID: 11264363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of LMP1 in immune control of EBV infection.
    Pai S; Khanna R
    Semin Cancer Biol; 2001 Dec; 11(6):455-60. PubMed ID: 11669607
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-Barr virus exploits host endocytic machinery for cell-to-cell viral transmission rather than a virological synapse.
    Nanbo A; Kachi K; Yoshiyama H; Ohba Y
    J Gen Virol; 2016 Nov; 97(11):2989-3006. PubMed ID: 27655016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toward standardization of Epstein-Barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen.
    Stevens SJ; Pronk I; Middeldorp JM
    J Clin Microbiol; 2001 Apr; 39(4):1211-6. PubMed ID: 11283029
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.
    de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM
    HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue.
    Bornkamm GW
    Semin Cancer Biol; 2009 Dec; 19(6):351-65. PubMed ID: 19619654
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alternating host cell tropism shapes the persistence, evolution and coexistence of epstein-barr virus infections in human.
    Huynh GT; Adler FR
    Bull Math Biol; 2011 Aug; 73(8):1754-73. PubMed ID: 20972716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Viral and host factors drive a type 1 Epstein-Barr virus spontaneous lytic phenotype.
    Willard KA; Barry AP; Oduor CI; Ong'echa JM; Bailey JA; Moormann AM; Luftig MA
    mBio; 2023 Dec; 14(6):e0220423. PubMed ID: 37971257
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epstein-Barr virus (EBV)-associated lymphoid lesions of the head and neck.
    Auerbach A; Aguilera NS
    Semin Diagn Pathol; 2015 Jan; 32(1):12-22. PubMed ID: 25804341
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical characteristics, outcome and the role of viral load in nontransplant patients with Epstein-Barr viraemia.
    Martelius T; Lappalainen M; Aalto SM; Nihtinen A; Hedman K; Anttila VJ
    Clin Microbiol Infect; 2010 Jun; 16(6):657-62. PubMed ID: 19694766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Epstein-Barr Virus LMP1 oncogene variants in cell lines of different origin].
    Yakovleva LS; Senyuta NB; Goncharova EV; Scherback LN; Smirnova RV; Pavlish OA; Gurtsevitch VE
    Mol Biol (Mosk); 2015; 49(5):800-10. PubMed ID: 26510598
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunotherapy for Epstein-Barr virus-associated malignancies.
    Long HM; Parsonage G; Fox CP; Lee SP
    Drug News Perspect; 2010 May; 23(4):221-8. PubMed ID: 20520851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis.
    Gregory CD; Dive C; Henderson S; Smith CA; Williams GT; Gordon J; Rickinson AB
    Nature; 1991 Feb; 349(6310):612-4. PubMed ID: 1705663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular biology of EBV in relationship to AIDS-associated oncogenesis.
    Bajaj BG; Murakami M; Robertson ES
    Cancer Treat Res; 2007; 133():141-62. PubMed ID: 17672040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epstein-Barr virus-associated lymphoid malignancies: the expanding spectrum of hematopoietic neoplasms.
    Kimura H; Kawada J; Ito Y
    Nagoya J Med Sci; 2013 Aug; 75(3-4):169-79. PubMed ID: 24640173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cholesterol-dependent infection of Burkitt's lymphoma cell lines by Epstein-Barr virus.
    Katzman RB; Longnecker R
    J Gen Virol; 2003 Nov; 84(Pt 11):2987-2992. PubMed ID: 14573803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular Biology of EBV in Relationship to HIV/AIDS-Associated Oncogenesis.
    Lang F; Pei Y; Lamplugh ZL; Robertson ES
    Cancer Treat Res; 2019; 177():81-103. PubMed ID: 30523622
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients.
    Pietersma F; Piriou E; van Baarle D
    Leuk Lymphoma; 2008 Jun; 49(6):1028-41. PubMed ID: 18452077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interactions between Epstein-Barr virus and the cell cycle control machinery.
    Sinclair AJ; Fenton M; Delikat S
    Histol Histopathol; 1998 Apr; 13(2):461-7. PubMed ID: 9589903
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epstein-Barr virus and cancer.
    Thompson MP; Kurzrock R
    Clin Cancer Res; 2004 Feb; 10(3):803-21. PubMed ID: 14871955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.